Spire Wealth Management Day One Biopharmaceuticals, Inc. Transaction History
Spire Wealth Management
- $3.01 Billion
- Q1 2024
A detailed history of Spire Wealth Management transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 40 shares of DAWN stock, worth $551. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40
Previous 40
-0.0%
Holding current value
$551
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$88.6 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$69.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$65.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$52.5 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$39.9 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.01B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...